Run-Ling Wang

According to our database, Run-Ling Wang authored at least 6 papers between 2018 and 2021.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2021

Design, synthesis, biological evaluation and molecular dynamics of LAR inhibitors.

Ying-Zhan Sun, Jing-Wei Wu, Shan Du, Yang-Chun Ma, Liang Zhou, Ying Ma, Run-Ling Wang

Comput. Biol. Chem., 2021

2019

Structure based design of selective SHP2 inhibitors by De novo design, synthesis and biological evaluation.

Wen-Shan Liu, Wen-Yan Jin, Liang Zhou, Xing-Hua Lu, Wei-Ya Li, Ying Ma, Run-Ling Wang

J. Comput. Aided Mol. Des., 2019

Exploring the reason for increased activity of SHP2 caused by D61Y mutation through molecular dynamics.

Rui-Rui Wang, Ying Ma, Shan Du, Wei-Ya Li, Ying-Zhan Sun, Hui Zhou, Run-Ling Wang

Comput. Biol. Chem., 2019

Exploring the effect of aplidin on low molecular weight protein tyrosine phosphatase by molecular docking and molecular dynamic simulation study.

Ying-Zhan Sun, Jing-Wei Wu, Xin-Hua Lu, Ying Ma, Run-Ling Wang

Comput. Biol. Chem., 2019

2018

3D QSAR Pharmacophore Based Virtual Screening for Identification of Potential Inhibitors for CDC25B.

Hong-Lian Li, Xiu-Bo Chen, Wen-Yan Jin, Hui Zhou, Ying Ma, Run-Ling Wang

Comput. Biol. Chem., 2018

Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamics.

Wen-Yan Jin, Ying Ma, Wei-Ya Li, Hong-Lian Li, Run-Ling Wang

Comput. Biol. Chem., 2018